标题
Genetic assessment in primary hyperoxaluria: why it matters
作者
关键词
-
出版物
PEDIATRIC NEPHROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-06-13
DOI
10.1007/s00467-022-05613-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis
- (2022) Nicolas Cornière et al. JOURNAL OF MEDICAL GENETICS
- The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants
- (2022) Marie-Noëlle Méaux et al. PEDIATRIC NEPHROLOGY
- Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry
- (2022) Lisa J. Deesker et al. Kidney International Reports
- Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2
- (2021) Prince Singh et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3
- (2021) Cristina Martin-Higueras et al. KIDNEY INTERNATIONAL
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
- (2021) Sander F. Garrelfs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, pharmacodynamics, and exposure-response modeling results from a first in human phase 1 study of nedosiran in primary hyperoxaluria.
- (2021) Bernd Hoppe et al. KIDNEY INTERNATIONAL
- Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients
- (2021) Sander F. Garrelfs et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
- (2021) Elisabeth L. Metry et al. Kidney International Reports
- The ILE56 mutation on different genetic backgrounds of alanine: Glyoxylate aminotransferase: Clinical features and biochemical characterization
- (2020) Mirco Dindo et al. MOLECULAR GENETICS AND METABOLISM
- Characteristics of the genotype and phenotype in Chinese primary hyperoxaluria type 1 populations
- (2020) Fangzhou Zhao et al. Urolithiasis
- Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) AGXT Gene Mutation
- (2020) Prince Singh et al. Kidney International Reports
- Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases
- (2020) Elizabeth C. Lorenz et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The ocular phenotype in primary hyperoxaluria type 1
- (2019) Johannes Birtel et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children
- (2019) Xiaoliang Fang et al. PEDIATRIC NEPHROLOGY
- Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up
- (2019) Sander F. Garrelfs et al. KIDNEY INTERNATIONAL
- Primary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries
- (2017) Jamsheer Jehangir Talati et al. Urolithiasis
- Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T
- (2016) Mirco Dindo et al. BIOCHIMIE
- Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria
- (2016) Alessandra Pelle et al. JOURNAL OF NEPHROLOGY
- Urine oxalate biological variation in patients with primary hyperoxaluria
- (2016) Oliver Clifford-Mobley et al. Urolithiasis
- Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine
- (2015) Riccardo Montioli et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Bone impairment in oxalosis: An ultrastructural bone analysis
- (2015) Justine Bacchetta et al. BONE
- AGXTGene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population
- (2015) Lamiae Boualla et al. Genetic Testing and Molecular Biomarkers
- Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I
- (2015) Elisa Oppici et al. HUMAN MOLECULAR GENETICS
- Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
- (2015) K. Hopp et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Progressive polyradiculoneuropathy due to intraneural oxalate deposition in type 1 primary hyperoxaluria
- (2015) Sarah E. Berini et al. MUSCLE & NERVE
- Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice
- (2014) H. Hoyer-Kuhn et al. Clinical Journal of the American Society of Nephrology
- Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type
- (2014) Giorgia Mandrile et al. KIDNEY INTERNATIONAL
- The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type I
- (2014) Noel Mesa-Torres et al. PLoS One
- Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase
- (2013) Elisa Oppici et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1
- (2013) Sonia Fargue et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes
- (2013) Barbara Cellini et al. CLINICAL BIOCHEMISTRY
- Primary Hyperoxaluria
- (2013) Pierre Cochat et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary hyperoxalurias: Disorders of glyoxylate detoxification
- (2012) Eduardo Salido et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies
- (2012) Bodo B Beck et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Primary hyperoxaluria type III—a model for studying perturbations in glyoxylate metabolism
- (2012) Ruth Belostotsky et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3
- (2012) E. L. Williams et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
- (2012) P. Cochat et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
- (2010) Ruth Belostotsky et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants
- (2010) Barbara Cellini et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Cardiac Abnormalities in Primary Hyperoxaluria
- (2010) Farouk Mookadam et al. CIRCULATION JOURNAL
- Primary hyperoxaluria type 1: update and additional mutation analysis of theAGXTgene
- (2009) Emma L. Williams et al. HUMAN MUTATION
- Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation
- (2009) Barbara Cellini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome
- (2009) Jérôme Harambat et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search